drugset / Trial / NCT07100249
A Study of HDM2012 in Patients With Advanced Solid Tumor
NaSequentialOpen-labelTreatment
Summary
This is a first-in-human (FIH) study to evaluate the safety and preliminary efficacy of experimental drug HDM2012 in patients with advanced solid tumors.
Timeline
- Start
- 2025-08-06
- Primary completion
- 2027-10
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HDM2012 | Unknown | — | Intravenous |